Patient clinical data
| LCL . | Sex . | Age . | Diagnosis of leukemia . |
|---|---|---|---|
| L-1 | M | 1 y | ALL |
| L-2 | F | 2 mo | ALL |
| L-3 | F | 2 mo | ALL |
| L-4 | F | 1 y 5 mo | ALL |
| L-5 | M | 1 y 11 mo | AML (M5) |
| L-6 | F | 1 y 3 mo | AML (M5a) |
| L-7 | F | 1 y 4 mo | AML (M5b) |
| LCL . | Sex . | Age . | Diagnosis of leukemia . |
|---|---|---|---|
| L-1 | M | 1 y | ALL |
| L-2 | F | 2 mo | ALL |
| L-3 | F | 2 mo | ALL |
| L-4 | F | 1 y 5 mo | ALL |
| L-5 | M | 1 y 11 mo | AML (M5) |
| L-6 | F | 1 y 3 mo | AML (M5a) |
| L-7 | F | 1 y 4 mo | AML (M5b) |
MLL gene rearrangement was seen in leukemia samples from all the patients in this study. AML was classified according to the French-American-British classification. LCL indicates lymphoblastoid cell line; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia.